Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Xigris approved in E.U.

Aug. 28, 2002

Sankyo files supplemental NDA for Benicar HCT

Aug. 28, 2002

Discovery and synthesis of the clinical candidate CP-608039 reported at ACS

Aug. 22, 2002

Early clinical data discussed for the adenosine A1 antagonist BG-9928

Aug. 22, 2002

Schering AG in-licenses further rights to fasudil

Aug. 22, 2002

Abbott describes novel alphavbeta3 receptor modulators with potential in cardiovascular disorders

Aug. 22, 2002

Diovan receives approval as heart failure therapy in U.S.

Aug. 22, 2002

Lilly claims sPLA2 inhibitors with potential in sepsis and other inflammatory disorders

Aug. 21, 2002

Merck claims alphavbeta3 and/or alphavbeta6 antagonists for cardiovascular and other disorders

Aug. 20, 2002

Crucell licenses PER.C6 cell line for use in GenVec's BioBypass

Aug. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...